Zeroing In: Ending the HIV Epidemic Grant Program supports community organizations delivering HIV prevention, care, digital innovation and outreach to improve health in communities most impacted by HIV.
Funder: Gilead Sciences
Due Dates: Due Dates (Anticipated): Not yet announced
Funding Amounts: $24 million awarded across the program to date
Summary: Supports community-driven HIV prevention, care, digital innovation and outreach for populations most impacted by HIV worldwide.
Key Information: Projects must prioritize key populations identified in local ending-the-HIV-epidemic plans and align with established EHE goals.
Gilead Sciences’ Zeroing In: Ending the HIV Epidemic grant program supports organizations working to improve the health and wellness of communities most impacted by HIV worldwide. It recognizes the role of community-based and grassroots organizations in delivering high-quality, supportive HIV prevention and care services. Supported approaches include local community programming, multi-organization community-driven projects and coalition-led efforts.
The program focuses on digital health innovations, community outreach and education, and comprehensive HIV innovation programs. Its goals include reducing health disparities, improving access to quality healthcare, advancing medical education and supporting local communities. Projects align with established international and country-specific ending-the-HIV-epidemic (EHE) goals and prioritize populations identified in local EHE plans.